Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Total Current Liabilities (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Total Current Liabilities for 16 consecutive years, with $22.0 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 60.04% to $22.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.0 million through Dec 2025, down 60.04% year-over-year, with the annual reading at $22.0 million for FY2025, 60.04% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $22.0 million at Harvard Bioscience, down from $54.4 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $55.6 million in Q1 2025, with the low at $20.7 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $29.9 million, with a median of $23.4 million recorded in 2021.
  • Peak annual rise in Total Current Liabilities hit 144.03% in 2025, while the deepest fall reached 60.04% in 2025.
  • Over 5 years, Total Current Liabilities stood at $25.3 million in 2021, then fell by 8.16% to $23.2 million in 2022, then rose by 14.16% to $26.5 million in 2023, then soared by 107.06% to $55.0 million in 2024, then plummeted by 60.04% to $22.0 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $22.0 million, $54.4 million, and $55.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.